Replies to post #3834 on Repros Therapeutics, Inc. (RPRX)

[docbanker]

Not being a smart a** but i would listen to replay.

i) endo trial ongoing with enrollment picked up
ii) 4 fibroids trials (2 anemia and 2 chronic) are starting with 1st dose in may- now doing finalization of setting up sites
iii) should report 2nd round of open label fibroid efficacy data here by end of month- safety already reported per PR last week. no d+cs or safety ises. should have 3rd round of open label done by summer with results shortly thereafter.
iv) raise $ late summer of Fall by worldwide partnership or small financing. Right now 11-13 companies under CDA with 7 one:one meetings going on - data room set up etc.
v) subjectively he is more confident in Proellex than ever.
vi) Androxal 2 PIIbs to start May/June with one in NYC led by key urologists and one i think at Harvard.